Lawrence B. Cohen’s Novartis NVS Stock Holding History

Lawrence B. Cohen’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,344	Closed	-$2.58M	–	42
2023 Q3	$2.58M	Buy	25,344 +330	+1%	+$33.5K	1.74%	24
2023 Q2	$2.52M	Sell	25,014 -118	-0.5%	-$11.8K	1.62%	23
2023 Q1	$2.31M	Buy	25,132 +1,093	+5%	+$95.5K	1.55%	27
2022 Q4	$2.18M	Buy	24,039 +380	+2%	+$32K	1.14%	35
2022 Q3	$1.8M	Sell	23,659 -857	-3%	-$71K	1.39%	34
2022 Q2	$2.07M	Sell	24,516 -1,167	-5%	-$102K	1.48%	36
2022 Q1	$2.25M	Sell	25,683 -144	-0.6%	-$12.5K	1.34%	36
2021 Q4	$2.26M	Sell	25,827 -2,995	-10%	-$249K	0.88%	48
2021 Q3	$2.36M	Sell	28,822 -1,459	-5%	-$131K	1.24%	39
2021 Q2	$2.76M	Buy	30,281 +232	+0.8%	+$20.7K	1.41%	34
2021 Q1	$2.57M	Sell	30,049 -320	-1%	-$28.7K	1.39%	31
2020 Q4	$2.87M	Buy	30,369 +242	+0.8%	+$21.1K	1.59%	26
2020 Q3	$2.62M	Buy	30,127 +62	+0.2%	+$5.37K	1.59%	24
2020 Q2	$2.63M	Sell	30,065 -91	-0.3%	-$7.86K	1.75%	22
2020 Q1	$2.49M	Buy	30,156 +1,050	+4%	+$93.7K	1.95%	18
2019 Q4	$2.76M	Buy	29,106 +448	+2%	+$40.2K	1.63%	27
2019 Q3	$2.49M	Sell	28,658 -673	-2%	-$60.4K	1.63%	28
2019 Q2	$2.68M	Sell	29,331 -3,955	-12%	-$335K	1.85%	25
2019 Q1	$2.87M	Sell	33,286 -49	-0.1%	-$3.93K	2.02%	22
2018 Q4	$2.56M	Buy	33,335 +363	+1%	+$28.3K	1.99%	23
2018 Q3	$2.55M	Buy	32,972 +558	+2%	+$41.3K	1.73%	28
2018 Q2	$2.19M	Sell	32,414 -2,009	-6%	-$139K	1.57%	30
2018 Q1	$2.49M	Buy	34,423 +1,680	+5%	+$128K	1.67%	28
2017 Q4	$2.46M	Buy	32,743 +623	+2%	+$47K	1.56%	30
2017 Q3	$2.47M	Buy	32,120 +2,386	+8%	+$180K	1.61%	28
2017 Q2	$2.22M	Buy	29,734 +955	+3%	+$67.7K	1.42%	31
2017 Q1	$1.92M	Buy	28,779 +4,218	+17%	+$281K	1.18%	31
2016 Q4	$1.6M	Buy	24,561 +13,537	+123%	+$878K	0.97%	32
2016 Q3	$780K	Buy	11,024 +3,917	+55%	+$285K	0.46%	46
2016 Q2	$525K	Buy	7,107 +190	+3%	+$13.1K	0.31%	53
2016 Q1	$449K	Buy	6,917 +402	+6%	+$27.3K	0.29%	52
2015 Q4	$503K	Buy	6,515 +111	+2%	+$8.82K	0.34%	50
2015 Q3	$527K	Hold	6,404	–	–	0.37%	46
2015 Q2	$564K	Hold	6,404	–	–	0.36%	45
2015 Q1	$566K	Sell	6,404 -156	-2%	-$13.8K	0.35%	44
2014 Q4	$544K	Buy	6,560 +1,897	+41%	+$157K	0.33%	49
2014 Q3	$393K	Sell	4,663 -36	-0.8%	-$2.91K	0.26%	53
2014 Q2	$381K	Hold	4,699	–	–	0.25%	55
2014 Q1	$358K	Sell	4,699 -298	-6%	-$21.7K	0.25%	52
2013 Q4	$360K	Hold	4,997	–	–	0.26%	52
2013 Q3	$344K	Buy	4,997 +446	+10%	+$29.5K	0.26%	51
2013 Q2	$288K	Buy	+4,551	New	+$296K	0.21%	54

Other funds holding NVS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lawrence B. Cohen's NVS Position: Q4 2023 in Review

Lawrence B. Cohen sold out of Novartis (NVS) in Q4 2023, closing a stake of 25,344 shares — an estimated $2.58M sold.

Lawrence B. Cohen first reported a position in NVS in Q2 2013 and held it in 42 quarters. The position peaked at $2.87M in Q4 2020. 1,273 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

Lawrence B. Cohen reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
Lawrence B. Cohen sold 25,344 Novartis shares in Q4 2023, an estimated $2.58M.
Lawrence B. Cohen first reported a position in Novartis in Q2 2013 and held it in 42 quarters.
Lawrence B. Cohen's Novartis position peaked at $2.87M in Q4 2020.
1,273 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.